Work

Abstract B84: Preclinical analysis of combinatorial glioblastoma therapy with the prodrug-mediated gene therapy vector AdV-TK and immune checkpoint inhibition

Year: 2017

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.tumimm16-b84

Authors: Maria Carmela Speranza, Franz Ricklefs, Carmela Passaro, Sarah R. Klein, Kazue Kasai, Johanna Kaufmann, Hiroshi Nakashima, Bronisz Agnieszka, Estuardo Aguilar-Cordova, Brian W. Guzik, Gordon J. Freeman, David A. Reardon, Patrick Wen, E. Antonio Chiocca, Sean E. Lawler

Institutions: Brigham and Women's Hospital, Harvard University, University Medical Center Hamburg-Eppendorf, Dana-Farber Cancer Institute, Advantagene (United States)

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594777667

Cites:

Cited by:

Related to: 10